Parametric Portfolio Associates’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $30.9M | Sell |
189,206
-16,492
| -8% | -$2.69M | 0.02% | 747 |
|
|
2021
Q4 | $34.9M | Sell |
205,698
-2,839
| -1% | -$481K | 0.02% | 700 |
|
|
2021
Q3 | $39.4M | Buy |
208,537
+9,852
| +5% | +$1.86M | 0.02% | 628 |
|
|
2021
Q2 | $33.7M | Buy |
198,685
+17,743
| +10% | +$3.01M | 0.02% | 719 |
|
|
2021
Q1 | $25.5M | Buy |
180,942
+17,158
| +10% | +$2.42M | 0.01% | 985 |
|
|
2020
Q4 | $21.3M | Buy |
163,784
+10,210
| +7% | +$1.33M | 0.01% | 1004 |
|
|
2020
Q3 | $22.4M | Sell |
153,574
-8,216
| -5% | -$1.2M | 0.02% | 833 |
|
|
2020
Q2 | $24M | Buy |
161,790
+7,370
| +5% | +$1.09M | 0.02% | 774 |
|
|
2020
Q1 | $16.8M | Buy |
154,420
+13,198
| +9% | +$1.44M | 0.02% | 882 |
|
|
2019
Q4 | $16.3M | Sell |
141,222
-56,166
| -28% | -$6.47M | 0.01% | 1122 |
|
|
2019
Q3 | $15.9M | Buy |
197,388
+44,701
| +29% | +$3.59M | 0.01% | 1089 |
|
|
2019
Q2 | $11.1M | Buy |
152,687
+12,718
| +9% | +$923K | 0.01% | 1371 |
|
|
2019
Q1 | $13.1M | Buy |
139,969
+42,369
| +43% | +$3.96M | 0.01% | 1220 |
|
|
2018
Q4 | $7.12M | Buy |
97,600
+4,969
| +5% | +$362K | 0.01% | 1603 |
|
|
2018
Q3 | $8.11M | Buy |
92,631
+14,016
| +18% | +$1.23M | 0.01% | 1605 |
|
|
2018
Q2 | $7.74M | Sell |
78,615
-451
| -0.6% | -$44.4K | 0.01% | 1572 |
|
|
2018
Q1 | $9.42M | Buy |
79,066
+4,876
| +7% | +$581K | 0.01% | 1381 |
|
|
2017
Q4 | $9.43M | Buy |
74,190
+10,878
| +17% | +$1.38M | 0.01% | 1368 |
|
|
2017
Q3 | $7.44M | Sell |
63,312
-768
| -1% | -$90.2K | 0.01% | 1515 |
|
|
2017
Q2 | $5.11M | Buy |
64,080
+4,050
| +7% | +$323K | 0.01% | 1754 |
|
|
2017
Q1 | $3.08M | Buy |
60,030
+24,967
| +71% | +$1.28M | ﹤0.01% | 2162 |
|
|
2016
Q4 | $1.31M | Sell |
35,063
-10,912
| -24% | -$409K | ﹤0.01% | 2663 |
|
|
2016
Q3 | $3.12M | Buy |
45,975
+7,898
| +21% | +$535K | ﹤0.01% | 1995 |
|
|
2016
Q2 | $2.11M | Buy |
38,077
+11,198
| +42% | +$621K | ﹤0.01% | 2291 |
|
|
2016
Q1 | $1.69M | Sell |
26,879
-12,710
| -32% | -$798K | ﹤0.01% | 2538 |
|
|
2015
Q4 | $3.73M | Buy |
39,589
+9,373
| +31% | +$882K | 0.01% | 1649 |
|
|
2015
Q3 | $2.43M | Sell |
30,216
-6,605
| -18% | -$531K | ﹤0.01% | 1698 |
|
|
2015
Q2 | $4.41M | Buy |
36,821
+8,196
| +29% | +$983K | 0.01% | 1467 |
|
|
2015
Q1 | $2.99M | Buy |
28,625
+4,259
| +17% | +$445K | 0.01% | 1842 |
|
|
2014
Q4 | $2.36M | Buy |
24,366
+10,908
| +81% | +$1.06M | 0.01% | 2019 |
|
|
2014
Q3 | $1.05M | Buy |
13,458
+491
| +4% | +$38.3K | ﹤0.01% | 2649 |
|
|
2014
Q2 | $819K | Sell |
12,967
-8,004
| -38% | -$506K | ﹤0.01% | 2861 |
|
|
2014
Q1 | $1.41M | Sell |
20,971
-497
| -2% | -$33.4K | ﹤0.01% | 2358 |
|
|
2013
Q4 | $1.38M | Sell |
21,468
-2,767
| -11% | -$178K | ﹤0.01% | 2386 |
|
|
2013
Q3 | $1.55M | Sell |
24,235
-2,816
| -10% | -$180K | ﹤0.01% | 2177 |
|
|
2013
Q2 | $839K | Buy |
+27,051
| New | +$839K | ﹤0.01% | 2567 |
|